Novartis AG
SIX:NOVN
Balance Sheet
Balance Sheet Decomposition
Novartis AG
Current Assets | 26.4B |
Cash & Short-Term Investments | 9.6B |
Receivables | 8.3B |
Other Current Assets | 8.6B |
Non-Current Assets | 67.9B |
Long-Term Investments | 2.6B |
PP&E | 10.5B |
Intangibles | 49.3B |
Other Non-Current Assets | 5.4B |
Current Liabilities | 29.3B |
Accounts Payable | 4.1B |
Other Current Liabilities | 25.2B |
Non-Current Liabilities | 25.4B |
Long-Term Debt | 18.7B |
Other Non-Current Liabilities | 6.7B |
Balance Sheet
Novartis AG
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
13 023
|
4 674
|
7 007
|
8 860
|
13 271
|
11 112
|
9 658
|
12 407
|
7 517
|
13 393
|
|
Cash |
3 607
|
3 074
|
1 912
|
2 970
|
3 121
|
3 247
|
3 750
|
3 396
|
2 877
|
3 207
|
|
Cash Equivalents |
9 416
|
1 600
|
5 095
|
5 890
|
10 150
|
7 865
|
5 908
|
9 011
|
4 640
|
10 186
|
|
Short-Term Investments |
480
|
628
|
539
|
487
|
2 447
|
122
|
1 635
|
15 706
|
11 209
|
680
|
|
Total Receivables |
10 258
|
10 553
|
10 208
|
11 101
|
11 036
|
10 337
|
10 036
|
9 621
|
9 894
|
9 376
|
|
Accounts Receivables |
8 278
|
8 182
|
8 203
|
8 601
|
8 739
|
8 301
|
8 217
|
8 005
|
8 066
|
7 107
|
|
Other Receivables |
1 980
|
2 371
|
2 005
|
2 500
|
2 297
|
2 036
|
1 819
|
1 616
|
1 828
|
2 269
|
|
Inventory |
6 093
|
6 226
|
6 255
|
6 867
|
6 956
|
5 982
|
7 131
|
6 666
|
7 175
|
5 913
|
|
Other Current Assets |
7 707
|
764
|
922
|
893
|
1 853
|
1 951
|
1 213
|
1 318
|
1 115
|
1 119
|
|
Total Current Assets |
37 561
|
22 845
|
24 931
|
28 208
|
35 563
|
29 504
|
29 673
|
45 718
|
36 910
|
30 481
|
|
PP&E Net |
15 983
|
15 982
|
15 641
|
16 464
|
15 696
|
13 746
|
13 939
|
13 106
|
12 195
|
10 924
|
|
PP&E Gross |
15 983
|
15 982
|
15 641
|
16 464
|
15 696
|
13 746
|
13 939
|
13 106
|
12 195
|
10 924
|
|
Accumulated Depreciation |
15 445
|
15 466
|
15 655
|
17 546
|
18 332
|
14 930
|
15 955
|
15 602
|
14 109
|
11 879
|
|
Intangible Assets |
23 832
|
34 217
|
31 340
|
29 997
|
38 719
|
28 787
|
36 809
|
34 182
|
31 644
|
26 879
|
|
Goodwill |
29 311
|
31 174
|
30 980
|
31 750
|
35 294
|
26 524
|
29 999
|
29 595
|
29 301
|
23 341
|
|
Note Receivable |
712
|
1 203
|
1 100
|
968
|
908
|
624
|
922
|
973
|
948
|
985
|
|
Long-Term Investments |
9 440
|
16 577
|
15 400
|
16 645
|
9 789
|
10 538
|
11 611
|
2 268
|
1 606
|
1 827
|
|
Other Long-Term Assets |
8 548
|
9 558
|
10 732
|
9 047
|
9 594
|
8 647
|
4 825
|
5 953
|
4 849
|
5 508
|
|
Other Assets |
29 311
|
31 174
|
30 980
|
31 750
|
35 294
|
26 524
|
29 999
|
29 595
|
29 301
|
23 341
|
|
Total Assets |
125 387
N/A
|
131 556
+5%
|
130 124
-1%
|
133 079
+2%
|
145 563
+9%
|
118 370
-19%
|
127 778
+8%
|
131 795
+3%
|
117 453
-11%
|
99 945
-15%
|
|
Liabilities | |||||||||||
Accounts Payable |
5 419
|
5 668
|
4 873
|
5 169
|
5 556
|
5 424
|
5 403
|
5 553
|
5 146
|
4 926
|
|
Accrued Liabilities |
4 402
|
4 366
|
4 169
|
4 811
|
5 105
|
5 058
|
5 336
|
5 100
|
5 334
|
5 154
|
|
Short-Term Debt |
3 571
|
3 915
|
5 611
|
4 842
|
6 430
|
4 844
|
7 319
|
3 606
|
3 635
|
3 893
|
|
Current Portion of Long-Term Debt |
2 989
|
1 659
|
178
|
359
|
3 190
|
2 248
|
2 558
|
2 896
|
2 492
|
2 421
|
|
Other Current Liabilities |
10 592
|
8 100
|
7 378
|
8 222
|
9 326
|
10 690
|
12 443
|
13 053
|
12 049
|
9 996
|
|
Total Current Liabilities |
26 973
|
23 708
|
22 209
|
23 403
|
29 607
|
28 264
|
33 059
|
30 208
|
28 656
|
26 390
|
|
Long-Term Debt |
13 799
|
16 327
|
17 897
|
23 224
|
22 470
|
22 056
|
27 978
|
24 523
|
21 782
|
20 034
|
|
Deferred Income Tax |
6 099
|
6 355
|
6 657
|
5 168
|
7 475
|
5 867
|
3 141
|
3 070
|
2 686
|
2 248
|
|
Minority Interest |
78
|
76
|
59
|
59
|
78
|
77
|
68
|
167
|
81
|
83
|
|
Other Liabilities |
7 672
|
8 044
|
8 470
|
7 057
|
7 319
|
6 632
|
6 934
|
6 172
|
4 906
|
4 523
|
|
Total Liabilities |
54 621
N/A
|
54 510
0%
|
55 292
+1%
|
58 911
+7%
|
66 949
+14%
|
62 896
-6%
|
71 180
+13%
|
64 140
-10%
|
58 111
-9%
|
53 278
-8%
|
|
Equity | |||||||||||
Common Stock |
1 001
|
991
|
972
|
969
|
944
|
936
|
913
|
901
|
890
|
825
|
|
Retained Earnings |
69 868
|
80 379
|
81 148
|
77 639
|
82 191
|
59 274
|
57 157
|
70 989
|
63 540
|
49 649
|
|
Unrealized Security Profit/Loss |
0
|
461
|
348
|
386
|
206
|
0
|
0
|
0
|
198
|
158
|
|
Treasury Stock |
103
|
101
|
76
|
100
|
69
|
80
|
53
|
48
|
92
|
41
|
|
Other Equity |
0
|
4 684
|
7 560
|
4 726
|
4 658
|
4 656
|
1 419
|
4 187
|
4 798
|
3 608
|
|
Total Equity |
70 766
N/A
|
77 046
+9%
|
74 832
-3%
|
74 168
-1%
|
78 614
+6%
|
55 474
-29%
|
56 598
+2%
|
67 655
+20%
|
59 342
-12%
|
46 667
-21%
|
|
Total Liabilities & Equity |
125 387
N/A
|
131 556
+5%
|
130 124
-1%
|
133 079
+2%
|
145 563
+9%
|
118 370
-19%
|
127 778
+8%
|
131 795
+3%
|
117 453
-11%
|
99 945
-15%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
2 399
|
2 374
|
2 374
|
2 317
|
2 311
|
2 265
|
2 257
|
2 235
|
2 120
|
2 044
|